press ga pedal ou result deliv
deliv standout quarter neuromod share enjoy
substanti lift optim around get closer depress
opportun felt result segment need stellar push
share higher balanc ebit margin fairli close
model sg margin much higher estim due fx
extra cost establish salesforc new geographi like japan
arguabl disappoint news come call year-
long delay imthera though think livn intent becom
heavili involv trial/product design view posit
overal discuss valuat feel valu
diversifi large-cap mid-cap peer grow similar pace
mean depress work use metric arriv valuat
similar share alreadi trade today maintain neutral
rate feel continu quarterli beat and/or posit
momentum trd space lift share higher yet think
share trd soon either tear happi
plain tear opinion may decid
chang tide row neuromod busi ww neuromod
sale came well ahead model buoy re-impl
sentiva adopt row strength attribut direct sale
japan chang australia latin america reimburs
countri whether non-recur benefit skew
result quarter management reiter growth particularli
ou prone quarterli volatil
pipelin updat mix management continu make good progress
toward caisson prelud studi expect complet
shortli imthera believ trial delay due
major design flaw manag suggest need
enhanc algorithms/program well trial design
valuat maintain neutral rate risk page
btig estim compani document million except per share amount
pleas read import disclosur analyst certif appear appendix
consolid revenu total come better
cardiac surgeri cardiopulmonari sale ahead sustain double-digit
growth heart lung machin advanc circulatori support tandemlif
sale manag expect acceler
full year via salesforc expans turn heart valv sale fell y/i
larg result chang contract manufactur agreement
percev sale world-wide grow neuromod sale grew
y/i neuromod saw benefit end servic implant sentiva
account gener sale europ neuromod
growth benefit launch sentiva final mention
previous rest word neuromod sale improv result chang
busi model key market like japan latin america australia
adjust gross margin forecast despit
headwind unfavor currenc sg margin higher
model impact fx higher sg spend also
driven higher sale market spend spend revenu
better though compani continu incur higher cost y/i
support develop pipelin asset non-gaap oper
margin much improv report
actualsbtig estimate varianceconsolid surgeri good oper minor tax tax btig estim compani filingsal item million except per-shar percentag amountsal item present non-gaap basi exclud item varianc
revenu tweak world-wide neuromod sale upsid
howev trim heart valv estim shortfal
expect typic season impact push revenu
improv currenc model benefit vs
previous constant currenc revenu growth estim
previous margin keep forecast fairli
steadi final lower tax rate bit trend told
adj ep forecast move
rate neutral price-to-earnings basi share trade mani
livn peer large-cap mid-cap grow revenu similar place
altern share also trade mid cap name feel
grow faster long term appli multipl split differ
would see hypothet price target close
shade trade today think immedi accret growth
market could serv catalyst stock feel quit bit
good news price depress reaffirm coverag
decis could big disappoint btig provid price
target neutral-r stock
risk rate includ missing/b guidanc declin surgic avr
volum slow vn new patient growth competit issu fda
trials/develop unsuccess bid medicar coverag vn
growth btig estim compani filingsnewold chang
ntm capjohnson johnsonjnjund bdxnot scientificbsxbuy cap capresmedrmdnot medicalwmginot cap factset data btig estimatespr ex-amortev/salescagrcompanytickr ptpricemarket cap
non-gaap incom growthnacost good sold oper incom continu incom continu minor tax expens net share oper pre-tax net net net net oper calcul effect tax calcul effect tax btig estim compani reportsfor quarter tax-effect earn use tax rate deriv ep comparison purpos
consolid million machin includ report cc report cc system report cc report cc report cc heart report cc heart valv includ sutureless report cc report cc cc sorin btig estim compani note sub-seg within cardiopulmonari heart valv cardiac rhythm repres btig estim actual result attempt estim line item base histor provid sorin prior merger go-forward basi compani disclosur
